Idioma:

Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL)

Advani, Anjali S. ; Gibson, Sarah ; Douglas, Elizabeth ; Diacovo, Julia ; Elson, Paul ; Kalaycio, Matt ; Copelan, Ed ; Sekeres, Mikkael ; Sobecks, Ronald ; Sungren, Shawnda ; Lagoo, Anand ; Rizzieri, David ; Hsi, Eric

British journal of haematology, 2011-05, Vol.153 (4), p.504-507 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por

Enviar para

Título:
Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL)
Autor: Advani, Anjali S. ; Gibson, Sarah ; Douglas, Elizabeth ; Diacovo, Julia ; Elson, Paul ; Kalaycio, Matt ; Copelan, Ed ; Sekeres, Mikkael ; Sobecks, Ronald ; Sungren, Shawnda ; Lagoo, Anand ; Rizzieri, David ; Hsi, Eric
Assuntos: Acetylation ; acute lymphocytic leukaemia ; Adult ; Aged ; Biological and medical sciences ; Biomarkers, Tumor - metabolism ; Epidemiologic Methods ; Female ; Hematologic and hematopoietic diseases ; histone ; Histones - metabolism ; Humans ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Male ; Medical sciences ; Middle Aged ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism ; Prognosis ; Recurrence ; relapse ; Young Adult
É parte de: British journal of haematology, 2011-05, Vol.153 (4), p.504-507
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
Descrição: Summary Histone H4 acetylation was examined by immunohistochemistry in patients with acute lymphocytic leukaemia (ALL) in first relapse. Univariate and multivariate models identified correlates of complete remission (CR) and overall survival (OS). No variables were associated with achievement of CR. In multivariate analysis, weak histone H4 acetylation [Hazard Ratio (HR) 2·20, 95% confidence interval (CI) 0·93–5·23, P = 0·07], shorter interval from diagnosis to relapse (<9 vs. 9–24 vs. >24 months) (HR 1·82, 95% CI 1·20–2·75, P = 0·005), and central nervous system involvement (HR 3·43, 95% CI 1·31–8·99, P = 0·01) were independent poor prognostic factors for OS. These data provide a rationale for the use of histone deacetylase inhibitors in the treatment of relapsed ALL.
Editor: Oxford, UK: Blackwell Publishing Ltd
Idioma: Inglês

Links

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL)

Advani, Anjali S. ; Gibson, Sarah ; Douglas, Elizabeth ; Diacovo, Julia ; Elson, Paul ; Kalaycio, Matt ; Copelan, Ed ; Sekeres, Mikkael ; Sobecks, Ronald ; Sungren, Shawnda ; Lagoo, Anand ; Rizzieri, David ; Hsi, Eric

Oxford, UK: Blackwell Publishing Ltd

Buscando em bases de dados remotas. Favor aguardar.